Monogram Orthopaedics Common Stock Price To Sales
| MGRM Stock | 1.97 0.01 0.51% |
Monogram Orthopaedics Common fundamentals help investors to digest information that contributes to Monogram Orthopaedics' financial success or failures. It also enables traders to predict the movement of Monogram Stock. The fundamental analysis module provides a way to measure Monogram Orthopaedics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Monogram Orthopaedics stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 242.88 | 417.08 |
Monogram | Price To Sales |
Monogram Orthopaedics Common Company Price To Sales Analysis
Monogram Orthopaedics' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Monogram Orthopaedics Price To Sales | 186.13 X |
Most of Monogram Orthopaedics' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Monogram Orthopaedics Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Monogram Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Monogram Orthopaedics is extremely important. It helps to project a fair market value of Monogram Stock properly, considering its historical fundamentals such as Price To Sales. Since Monogram Orthopaedics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Monogram Orthopaedics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Monogram Orthopaedics' interrelated accounts and indicators.
Click cells to compare fundamentals
Monogram Price To Sales Historical Pattern
Today, most investors in Monogram Orthopaedics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Monogram Orthopaedics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Monogram Orthopaedics price to sales as a starting point in their analysis.
Monogram Orthopaedics Price To Sales |
| Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Monogram Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Monogram Orthopaedics Common has a Price To Sales of 186 times. This is much higher than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The price to sales for all United States stocks is notably lower than that of the firm.
Monogram Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Monogram Orthopaedics' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Monogram Orthopaedics could also be used in its relative valuation, which is a method of valuing Monogram Orthopaedics by comparing valuation metrics of similar companies.Monogram Orthopaedics is currently under evaluation in price to sales category among its peers.
Monogram Orthopaedics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Monogram Orthopaedics from analyzing Monogram Orthopaedics' financial statements. These drivers represent accounts that assess Monogram Orthopaedics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Monogram Orthopaedics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Enterprise Value | 343.5M | 338.3M | 338.4M | 333.9M | 64.0M | 60.8M |
Monogram Fundamentals
| Return On Equity | -1.22 | ||||
| Return On Asset | -0.61 | ||||
| Operating Margin | (40.76) % | ||||
| Current Valuation | 51.77 M | ||||
| Shares Outstanding | 34.31 M | ||||
| Shares Owned By Insiders | 34.22 % | ||||
| Shares Owned By Institutions | 3.84 % | ||||
| Number Of Shares Shorted | 256.64 K | ||||
| Price To Book | 3.90 X | ||||
| Price To Sales | 186.13 X | ||||
| Revenue | 365 K | ||||
| EBITDA | (16.86 M) | ||||
| Net Income | (13.75 M) | ||||
| Total Debt | 491.99 K | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | (13.54 M) | ||||
| Short Ratio | 3.00 X | ||||
| Earnings Per Share | (0.47) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 28 | ||||
| Market Capitalization | 67.94 M | ||||
| Total Asset | 16.58 M | ||||
| Retained Earnings | (51.51 M) | ||||
| Working Capital | 11.8 M | ||||
| Net Asset | 16.58 M |
About Monogram Orthopaedics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Monogram Orthopaedics Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Monogram Orthopaedics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Monogram Orthopaedics Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Monogram Orthopaedics Piotroski F Score and Monogram Orthopaedics Altman Z Score analysis. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.012 | Return On Assets (0.61) | Return On Equity (1.22) |
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.